T-Therapeutics

Advancing TCR bispecific therapies for cancer and autoimmune disorders.
Advancing TCR bispecific therapies for cancer and autoimmune disorders.

Investment Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, UK

Initial Investment

2023
T-Therapeutics

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.